Plasma Levels of Growth Arrest Specific Protein (Gas6) and the Soluble Form of Its Tyrosine Kinase Receptor Axl (sAxl) in Patients with Hepatocellular Carcinoma

Journals Menu

Follow SCIRP

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations h5-index & Ranking

"Plasma Levels of Growth Arrest Specific Protein (Gas6) and the Soluble Form of Its Tyrosine Kinase Receptor Axl (sAxl) in Patients with Hepatocellular Carcinoma"
written by Soichiro Uehara, Katsuhiro Gotoh, Hiroshi Handa, Yoshiyuki Maki,
published by Journal of Cancer Therapy, Vol.4 No.2, 2013

has been cited by the following article(s):

[1]	Intrinsic and Extrinsic Control of Hepatocellular Carcinoma by TAM Receptors
	Cancers, 2021

[2]	EVALUATING SOLUBLE AXL AS A BIOMARKER FOR GLIOBLASTOMA
	2020

[3]	Growth arrest-specific 6 und Soluble Axl als Biomarker bei pulmonaler Hypertonie
	2019 - Dissertation, Gieß en, 2019

[4]	Vitamin K Dependent Proteins in Kidney Disease
	2019

[5]	Role of Tyro3, Axl, and Mer Receptors and Their Ligands (Gas6, and Protein S) in Patients with Hepatocellular Carcinoma
	2017

[6]	The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis
	Cell Death & Disease, 2017

[7]	Role of Tyro3, Axl and Mer receptors and their ligands (Gas6 and Protein S) in patients with hepatocellular carcinoma
	2017

[8]	Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation
	Journal of hepatology, 2015

[1]	Gas6 in chronic liver disease—a novel blood-based biomarker for liver fibrosis Cell Death Discovery, 2023 DOI:10.1038/s41420-023-01551-6

[2]	Intrinsic and Extrinsic Control of Hepatocellular Carcinoma by TAM Receptors Cancers, 2021 DOI:10.3390/cancers13215448

[3]	Vitamin K Dependent Proteins in Kidney Disease International Journal of Molecular Sciences, 2019 DOI:10.3390/ijms20071571

[4]	Role of Tyro3, Axl, and Mer Receptors and Their Ligands (Gas6, and Protein S) in Patients with Hepatocellular Carcinoma Journal of Cancer Therapy, 2017 DOI:10.4236/jct.2017.82010

[5]	The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis Cell Death and Disease, 2017 DOI:10.1038/cddis.2017.554

[6]	The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosis Cell Death & Disease, 2017 DOI:10.1038/cddis.2017.554

[7]	Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation Journal of Hepatology, 2015 DOI:10.1016/j.jhep.2015.04.013

Follow SCIRP